EveryMatrix Completes Acquisition of Majority Shares in Fantasma
EveryMatrix's Strategic Move to Acquire Fantasma
EveryMatrix Software Limited has successfully finalized its public cash offer to acquire shares from the shareholders of Fantasma Games AB. With this strategic acquisition, EveryMatrix has achieved ownership of 95.19 percent of all shares in Fantasma. This decision marks a significant moment for both companies as they look toward a future of enhanced collaboration.
Details of the Acquisition Offer
The offer was introduced on September 18, 2024, at a price of SEK 59 per share, significantly attracting shareholder interest. Throughout the acceptance period, which concluded on October 10, 2024, EveryMatrix received acceptance from shareholders representing 85.65 percent of all shares. Excitingly, this level of interest underscores the strong support for the acquisition within the market.
Shareholder Engagement
During this acceptance timeframe, EveryMatrix also managed to secure an additional 150,000 shares externally, equating to 4.22 percent of the total shares in Fantasma. An important component came from a key stakeholder who committed to selling an additional 189,483 shares at the same offer price. The integration of these shares brings EveryMatrix's total ownership to an impressive 3,385,523 shares within Fantasma.
Completion and Next Steps
With all necessary conditions met for the offer's completion, EveryMatrix is expected to initiate the settlement process on or around October 18, 2024. This completion aligns with the firm's growth strategy, allowing it to solidify its position in the sector.
Compulsory Buy-out and Future Plans
Additionally, EveryMatrix intends to kick off a compulsory buy-out proceeding guided by the Swedish Companies Act to obtain the remaining shares held by minority stakeholders—further progressing its influence within Fantasma. Alongside this, EveryMatrix is exploring the possibilities for delisting Fantasma from the Nasdaq First North Growth Market.
Company Contact and Information
EveryMatrix has encouraged interested parties to contact them directly for inquiries linked to the offer. Although specific email addresses for inquiries have been omitted, they remain accessible for relevant stakeholders seeking more information about the acquisition or related details.
Frequently Asked Questions
What is the significance of EveryMatrix acquiring Fantasma?
This acquisition strengthens EveryMatrix's market position and expands its capabilities within the gaming industry.
What was the offer price for Fantasma shares?
EveryMatrix offered SEK 59 per share for the acquisition.
How much ownership does EveryMatrix now have in Fantasma?
EveryMatrix now owns 95.19 percent of all shares in Fantasma.
What is EveryMatrix's next step after the acquisition?
The company plans to conduct a compulsory buy-out for the remaining shares and aims to delist Fantasma from the public market.
How can I get more information about the offer?
Interested parties should reach out to EveryMatrix directly through their official communication channels for up-to-date information.
About Investors Hangout
Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/
Disclaimer: The content of this article is solely for general informational purposes only; it does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice; the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. The author's interpretation of publicly available data shapes the opinions presented here; as a result, they should not be taken as advice to purchase, sell, or hold any securities mentioned or any other investments. The author does not guarantee the accuracy, completeness, or timeliness of any material, providing it "as is." Information and market conditions may change; past performance is not indicative of future outcomes. If any of the material offered here is inaccurate, please contact us for corrections.
Related Articles
- GSK Reaches Major Settlements Over Zantac Lawsuits, Future Uncertain
- Murphy Law Firm Investigates Omni Family Health Data Breach
- Navigating Spotify Technology's Options Landscape: Key Insights
- Insights into DraftKings Options Trading Trends and Analysis
- Intellinetics Set to Showcase Innovations at Key Conference
- Analyzing W.W. Grainger's Current Market Dynamics and Trends
- Vernon Litigation Takes Action Against LPL Financial Over Investment Issues
- Innovative Men's Shirt Design Enhances Bathroom Convenience
- Bitcoin's Sideways Journey: Market Expectations and Trends
- Bitcoin's Bullish Trajectory: Predicting The Path Forward
Recent Articles
- Domino's Pizza Stock Price Target Increased Amid Market Challenges
- FDA Advisory Committee Supports Elamipretide for Barth Syndrome
- Paltalk Wins $65.7 Million Against Cisco in Patent Case
- AW Properties Global Announces Strategic Senior Living Development
- Tyra Biosciences Prepares for ENA 2024 with Promising Data
- Baird Medical Soars With Impressive Financial Growth Results
- Alignment Healthcare Achieves Impressive CMS Ratings for 2025
- Acrivon Enters Clinical Phase with Promising Cancer Drug ACR-2316
- Customer Experience Management Market on the Rise to $30.31B
- France's Budget Plan: A Tightrope Walk for Economic Stability
- Growth Projections for Enteral Feeding Devices Market revealed
- GEA Group Increases Earnings Forecast, Stock Sees Positive Upsurge
- Hearth Market Projected to Reach $13.4 Billion by 2029
- Hewlett Packard Enterprise's AI Day Highlights Key Innovations
- Somnia Launches Innovative World Builder for Creators
- Traders Cautiously Eye Bitcoin's Support at $58,000 Level
- Home BancShares Increases Reserves Amid Hurricane Challenges
- Will Gold Soar Further? Analyzing Market Influences
- Celestica Introduces Revolutionary DS4100 Switch for AI Workloads
- 23andMe Moves Forward with 1-for-20 Reverse Stock Split
- Ocean Power Technologies Showcases Innovations at Key Conference
- Royalty Pharma Announces Generous Q4 Dividend for Shareholders
- Main Street Financial Increases Investor Returns with Dividend
- Michelin Updates Shareholder Voting Rights and Capital Shares
- Acrivon Therapeutics Pushes Ahead with ACR-2316 Trials
- FangDD Successfully Meets Nasdaq Bid Price Criteria
- Investors Analyze Earnings Season Amid Inflation Concerns
- Nano Labs Achieves Compliance with Nasdaq Listing Requirements
- Palantir Joins S&P 500: What This Means for Your Investment
- SAIHEAT Limited's Strategic Response to Nasdaq Notification
- Paltalk Secures Final Judgment Against Cisco in Patent Case
- FDA Grants Approval for FoundationOne®Liquid CDx in Cancer Care
- Global Uranium Corp. Launches Ground Survey for Uranium Exploration
- KB Home Launches New Community Winslow Ridge in the Northwest
- Par Pacific Plans Q3 2024 Earnings Call with Investors
- KB Home Unveils Cypress Point: A New Coastal Community Experience
- Assertio Holdings Engages in Healthcare Virtual Summit 2024
- Tissue Diagnostics Market Set for Accelerated Growth Ahead
- Transforming Manufacturing: Hurco's AI Innovations Unveiled
- Celebrate 1.5 Years of Obey Me! Nightbringer with Exciting Events
- InnovAge's Commitment to Transforming Elderly Care Practices
- Exploring Growth Opportunities in Customer Experience Management
- Pottery Barn Launches Festive Collection for Polar Express 20th Anniversary
- Aligos Therapeutics Announces New Employee Stock Options Grants
- Paltalk Achieves Legal Victory with Final Judgment Against Cisco
- Lattice Semiconductor Names New Interim CFO to Drive Growth
- New Insights from Disc Medicine on Chronic Kidney Disease Treatment
- Exciting Updates on DISC-0974 for Chronic Kidney Disease Patients
- Sylvamo's Upcoming Earnings Release and Webcast Details
- Alignment Healthcare Achieves High Star Ratings for 2025 Plans